FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Taiho Oncology sNDA for Lonsurf in Gastric Tumors

[ Price : $8.95]

FDA accepts for priority review a Taiho Oncology supplemental NDA for Lonsurf (trifluridine/tipiracil, TAS-102) as a treatment for...

Mixed Vote on Cardio Risk Trials for Diabetes Drugs

[ Price : $8.95]

An FDA Advisory Committee delivers a mixed vote (10 to 9) in favor of continuing required cardiovascular outcomes trials for all n...

Info Collection Extension for REMS Requirements

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Prescription Drug Product Labeling; Me...

HHS Head Dismisses Industry Resistance to Drug Prices Plan

[ Price : $8.95]

Faced with resistance from the pharmaceutical industry, Health and Human Services Secretary and former Eli Lilly executive Alex Az...

Provide Reviews with CRLs: Attorneys

[ Price : $8.95]

Three Hyman, Phelps attorneys argue that CDER should change its current process and permit applicants who receive a complete respo...

Biopharmaceutical Classification Biowaivers Guidance

[ Price : $8.95]

FDA publishes a draft ICH guidance on biopharmaceutics classification system-based biowaivers.

Drug Development Testicular Toxicity Guide

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance entitled Testicular Toxicity: Evaluation During Drug Development.

Draft Guide on Drug Supplier Verification Systems

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Verification Systems Under the Drug Supply Chain Security A...

FDA Gets New Opioid Fight Authorities

[ Price : $8.95]

FDA commissioner Scott Gottlieb says the agency gained new authorities under the SUPPORT bill to combat the nations opioid crisis....

CDRH Posts ASCA Information

[ Price : $8.95]

CDRH posts information about its planned Accreditation Scheme for Conformity Assessment pilot program to accredit testing laborato...